Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05529030 · ClinicalTrials.gov registry record · NA
COVID-19 Booster Readiness Survey
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 12,036
- Enrollment target
NCT05529030: Completed NA study, sponsored by Geisinger Clinic.
NCT05529030 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 12,036 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (758% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05529030, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 12,036 participants
- Enrollment target
Study Summary
The purpose of this administrative survey is to inform health system logistics by assessing the attitudes towards towards the bivalent COVID-19 boosters held by healthcare workers (HCWs) at a large, rural health system. It will also test, prospectively, the effect on interest in the bivalent COVID-19 booster of different framing approaches in a survey question sent to employees of a large, rural health system.
Primary Outcome
Number of employees who indicate that they plan to get the booster when it is available
Interventions
- BEHAVIORAL Salience of Omicron variant
- BEHAVIORAL Self-protection message
- BEHAVIORAL Other-protection message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,036 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2022-09-15 |
| Phase | NA |
What the finished NCT05529030 record still lists
NCT05529030 is an interventional study that assigns participants to a tested intervention. Its 12,036 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (758% higher).
The record links to 0 conditions, and to 3 interventions - of which Salience of Omicron variant is the first listed.
NCT05529030 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05529030 about?
NCT05529030 is a clinical study titled "COVID-19 Booster Readiness Survey". The purpose of this administrative survey is to inform health system logistics by assessing the attitudes towards towards the bivalent COVID-19 boosters held by healthcare workers (HCWs) at a large, rural health system. It will also test, prospectively, the effect on interest in the bivalent COVID-1...
What is the current status of trial NCT05529030?
This trial is currently completed. It is a NA study. The enrollment target is 12,036 participants. The study started on 2022-09-01. Estimated completion is 2022-09-15.
What interventions are being tested in trial NCT05529030?
The interventions under investigation include: Salience of Omicron variant (BEHAVIORAL), Self-protection message (BEHAVIORAL), Other-protection message (BEHAVIORAL).
Who is sponsoring clinical trial NCT05529030?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05529030's enrollment target sits among peer trials
12,036 14th of 2000 higher than 1,987 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01772771 · 12,000 participants
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
- NCT04937868 · 12,000 participants
Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
- NCT06059963 · 12,000 participants
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
- NCT06273618 · 12,000 participants · NA
iLookOut Micro-learning to Improve Knowledge Retention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI